Compare Amphastar Pharmaceuticals Inc (AMPH) vs Super Micro Computer Inc (SMCI) Price & Performance

AMPH trades at $18.72, down 1.58% with bearish technical signals despite oversold RSI readings. The company reported mixed Q1 2026 results with EPS of $0.42 missing estimates of $0.70, continuing a trend of recent earnings disappointments. Valuation metrics appear reasonable with P/E of 11.29 and P/B of 1.07, while profitability remains solid with 47.34% gross margins. Recent news includes a Zacks Strong Sell rating and ongoing securities law investigation.

The stock faces near-term headwinds from earnings misses and negative analyst sentiment, though current valuations provide some downside protection. Upside potential exists if the company can execute its strategic pivot to proprietary drugs and biosimilars while managing BAQSIMI discount pressures. Key risks include ongoing legal scrutiny and competitive pressures in the generic drug market.

Super Micro Computer (SMCI) trades at $28.31, up 0.25% with bearish technical signals despite recent earnings beats. The stock faces headwinds from a Taiwan investigation into alleged AI server exports, contributing to a 36% decline in June. Fundamentally, the company shows strong revenue growth with $21.97B in 2025 and improved net income margins, but cash flow trends raise concerns with projected negative operating cash flow in 2026.

The investment outlook is mixed: valuation metrics appear attractive with P/E of 14.9 and P/S of 0.56, and analysts maintain a $36.43 price target. However, significant risks include the ongoing Taiwan probe, working capital pressures, and competitive threats in the AI infrastructure space that could impact future growth and margins.